#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Lymphangiosarcoma Autoimmune hepatitis Head and neck cancer Glycogen storage disease type II Thrombotic thrombocytopenic purpura Obliterative bronchiolitis Hepatocellular carcinoma Hereditary angioedema Leiomyosarcoma Alternating hemiplegia of childhood Leukodystrophy Hyperchylomicronaemia Hyperinsulinaemic hypoglycaemia Cushing's syndrome Leiomyosarcoma metastatic More trials…

    Learn about Rare Diseases

    Phenylketonuria – Treatment Paraneoplastic neurological syndrome – Diagnostics Urea cycle disorder – Trials in Disease Alport’s syndrome – Life with Disease Mantle cell lymphoma Langerhans cell sarcoma – Diagnostics Methylmalonic acidaemia Noonan syndrome – Diagnostics Bronchiolitis obliterans syndrome – Treatment Tuberous sclerosis complex – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Iclepertin Rtx001 GSKVX000000034795 Tiapride Mebeverine Hydrochloride Dexamethasone Acetate Ph. Eur. Fingolimod Doxecitine Degarelix Acetate Favezelimab Acalabrutinib 177LU-FAP-2286 Lumateperone Avacopan Ivabradine Letrozole 177LU-PSMA-I&T Samuraciclib BI-1607 ALG-000184 More therapies…

    Learn about Your Condition

    Toxic nodular goitre Chronic lymphocytic leukaemia Supranuclear palsy Endotracheal intubation Chorioretinitis Head injury Thrombocytosis Hepatorenal syndrome Nervous system disorder Renal cell carcinoma Nocturia Pancreatic carcinoma Heart disease congenital Nodal osteoarthritis Vulvar dysplasia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Bosentan for Treating Coronary Artery Spasm in Patients with Ongoing Angina Symptoms

    Recruiting

    4 1 1
    Investigated Diseases:
    • Arteriospasm coronary
    Investigated Drugs:
    • Acetylcholine Chloride
    • Microcrystalline Cellulose
    • Bosentan
    The Netherlands

  • Long-Term Safety Study of NTLA-2001 for Patients with Hereditary Transthyretin Amyloidosis with Polyneuropathy or Transthyretin Amyloidosis-Related Cardiomyopathy

    Recruiting

    4 1 1
    Investigated Diseases:
    • Hereditary neuropathic amyloidosis
    • Cardiac amyloidosis
    Investigated Drugs:
    • Single Guide Rna Targeting The Human Ttr Gene
    • Ziclumeran
    France Sweden

  • Study of Radium-224 in Patients with Advanced Ovarian, Fallopian Tube, or Peritoneal Cancer with Peritoneal Metastasis Undergoing Chemotherapy and Surgery

    Recruiting

    2 1 1
    Investigated Drugs:
    • Radium-224 Adsorbed In Calcium Carbonate Microparticles
    Belgium Italy Norway Spain

  • Study on Colchicine and Opium for Preventing Heart and Kidney Issues in Patients with Moderate Chronic Kidney Disease

    Recruiting

    3 1 1
    Investigated Diseases:
    • Nephropathy
    Investigated Drugs:
    • Opium, Standardized Powdered
    • Tiemonium Methylsulphate
    • Colchicine
    Spain

  • Study on Intermittent vs. Continuous Panitumumab and FOLFIRI for Patients with Unresectable Left-Sided Metastatic Colorectal Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Panitumumab
    Italy

  • Study of Amivantamab, Lazertinib, and Pemetrexed for Patients with Advanced or Metastatic Solid Tumors, Including EGFR-Mutated Non-Small Cell Lung Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Lazertinib
    • Amivantamab
    • Carboplatin
    France Germany Italy Spain
Previous Page
1 … 469 470 471 472 473 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!